Brett R. Hagen, Chief Accounting Officer: Kalaris Therapeutics KLRS Sell · Filed 03/23

Trade details

Type: Insider sale
Amount: $12,868.8
Shares · price: 1,915 sh · $6.72 a share
Held after: 0 sh
Stock: Kalaris Therapeutics KLRS
Person: Brett R. HagenChief Accounting Officer
Trade date: 26/03/20
Filed: 26/03/23
Days to filing: 3 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 02/18~04/19

Brett R. Hagen's recent trades

Brett R. HagenChief Accounting Officer
Planned saleKalaris Therapeutics
Planned sale
Kalaris Therapeutics
KLRS
$12.9K
1,915 sh
$12.9K
Filed 03/20
Traded 03/20
Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$8,136
907 sh
$8,136
Filed 25/03/27
Traded 25/03/26
Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$968
96 sh
$968
Filed 25/02/24
Traded 25/02/21
Brett R. HagenOfficer
Planned saleKalaris Therapeutics
Planned sale
Kalaris Therapeutics
KLRS
$967
96 sh
$967
Filed 25/02/24
Traded 25/02/21
Brett R. HagenChief Accounting Officer
SellKalaris Therapeutics
Sell
Kalaris Therapeutics
KLRS
$302
32 sh
$302
Filed 25/01/27
Traded 25/01/23